Fondren Management’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-25,136
Closed -$26K 110
2019
Q1
$26K Buy
+25,136
New +$26K 0.02% 82